28.83USD-9.97%Mkt Cap: 1.28B $P/E: 9.28Today
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an ora…

